Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid

Molecular Pharmacology

Volumn 46, Issue 3, 1994, Pages 516-522

  Pinto, Julia C ^a   Potié, Frederike ^a   Rice, Kenner C ^a   Boring, Daniel ^b   Johnson, M Ross ^a,d   Evans, David M ^c,e   Wilken, Gerald H ^c   Cantrell, Catherine H ^c   Howlett, Allyn C ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HFD 530   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d Parnassus Pharmaceutical Inc ^*  (United States)

^e PERKINELMER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CANNABINOID; GUANINE NUCLEOTIDE BINDING PROTEIN; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM CURRENT; DRUG CONFORMATION; DRUG RECEPTOR BINDING; HYDROGEN BOND; LIGAND BINDING; NONHUMAN; RAT; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; AMIDES; ANIMALS; ARACHIDONIC ACIDS; BINDING SITES; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTERS; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0027932775     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hewlett, A. C., M. Bidaut-Russell, W. A. Devane, L. S. Melvin, M. R. Johnson, and M. Herkenham. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 13:420-423 (1990).
2. Howlett, A. C., D. M. Evans, and D. B. Houston. The cannabinoid receptor, in Marijuana/Cannabinoids: Neurobiology and Neurophysiology (L. Murphy and A. Bartke, eds.). CRC Press, Boca Raton, FL, 35-72 (1992).
3. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Washington D. C.) 258:1946-1949 (1992).
4. Vogel, Z., J. Barg, R. Levy, D. Saya, E. Heldman, and R. Mechoulam. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61:352-355 (1993).
5. Johnson, D. E., S. L. Heald, R. D. Dally, and R. A. Janis. Isolation, identification and synthesis of an endogenous arachidonic amide. Prostaglandins Leukotrienes Essential Fatty Acids 48:429-437 (1993).
6. Felder, C. C., E. M. Briley, J. Axelrod, J. T. Simpson, K. Mackie, and W. A. Devane. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 90:7656-7660 (1993).
7. Schmid, H. H. O., P. C. Schmid, and V. Natarajan. N-Acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29:1-43 (1990).
8. Hanus, L., A. Gopher, S. Almog, and R. Mechoulam. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 36:3032-3034 (1993).
9. Devane, W. A., F. A. Dysarz III, M. R. Johnson, L. S. Melvin, and A. C. Howlett. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:605-613 (1988).
10. 3H]CP-55,940 binding to the cannabinoid receptor in brain. Biotech Update 6:21 (1991).
11. Howlett, A. C. Cannabinoid inhibition of adenylate cyclase: biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27:429-436 (1985).
12. Salomon, Y., C. Londos, and M. Rodbell. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548 (1974).
13. Corey, E. J., J. R. Cashman, S. S. Kantner, and S. W. Wright. Rationally designed, potent competitive inhibitors of leukotriene biosynthesis. J. Am. Chem. Soc. 106:1503-1504 (1984).
14. Deutsch, D. G., and S. A. Chin. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46:791-796 (1993).
15. Childers, S. R., T. Sexton, and M. B. Roy. Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47:711-715 (1994).
16. Umezawa, H., T. Aoyagi, K. Uotani, M. Hamada, T. Takeuchi, and S. Takahashi. Ebelactone, an inhibitor of esterase, produced by actinomycetes. J. Antibiot. (Tokyo) 33:1594-1596 (1980).
17. Scaloni, A., W. M. Jones, D. Barra, M. Pospischil, S. Sassa, A. Popowicz, L. R. Manning, O. Schneewind, and J. M. Manning. Acylpeptide hydrolase: inhibitors and some active site residues of the human enzyme. J. Biol. Chem. 267:3811-3818 (1992).
18. Tan, E. W., and R. R. Rando. Identification of an isoprenylated cysteine methyl ester hydrolase activity in bovine rod outer segment membranes. Biochemistry 31:5572-5578 (1992).
19. Mackie, K., W. A. Devane, and B. Hille. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44:498-503 (1993).
20. Milne, G. M., Jr., and M. R. Johnson. Levonantradol: a role for central prostanoid mechanisms? J. Clin. Pharmacol. 21(suppl.):367S-374S (1981).
21. 2+-dependent release from rat brain of cannabinoid receptor binding activity. J. Neurochem. 58:780-782 (1992).
22. Evans, D. M., J. T. Lake, M. R. Johnson, and A. C. Howlett. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. J. Pharmacol. Exp. Ther. 268:1271-1277 (1994).